Non-Hodgkin Lymphoma Perspective

• Episode 6: Bruton Tyrosine Kinase Inhibitors in Mantle Cell Lymphoma   Drs Peter Martin and Anita Kumar discuss covalent and noncovalent Bruton tyrosine kinase (BTK) inhibitors in the frontline setting, BTK mutations, and the complicated mechanisms of resistance.
  Medscape, May 31, 2023
• Episode 2: Monitoring and Management of CAR T-Cell Therapy Complications   Join Drs Amelia Langston and Jean Koff as they discuss the monitoring and management of complications before, during, and after CAR T-cell therapy.
  Medscape, May 11, 2023
• Episode 1: When Is CAR T-Cell Therapy the Answer?   Drs Amelia Langston and Melody Smith provide an overview of CAR T-cell therapy, the products available, potential complications, and what's next in this rapidly advancing field.
  Medscape, May 11, 2023
• Episode 5: Key Topics in the Pathology of Mantle Cell Lymphoma   Drs Peter Martin and Eric Hsi have a thought-provoking discussion on key topics in the pathology of mantle cell lymphoma, including biopsies, diagnostic markers, and what the future holds for treatment.
  Medscape, April 27, 2023
• Mantle Cell Lymphoma e-Tumor Boards: Case 1: MCL with TP53 Mutation   The e-Tumor Boards, a video series collaboration with Memorial Sloan Kettering Cancer Center, gives physicians an inside look into a virtual, multidisciplinary mantle cell lymphoma tumor board case discussion.
  Medscape, April 05, 2023
• Episode 4: CAR T Cells and Immunotherapy in Mantle Cell Lymphoma   Drs Peter Martin and Michael Wang discuss the role of CAR T cells in mantle cell lymphoma, how they are used with respect to bridging therapy, and the surveillance and management of toxicities.
  Medscape, March 30, 2023
• S2 Episode 3: Perioperative Management of Lung Cancer   Drs Jacob Sands and Jamie Chaft discuss the past, present, and future of perioperative management of lung cancer, including data from recent trials, disease-free survival outcomes, and changes in the standard of care.
  Medscape, March 16, 2023
• Episode 3: Bendamustine and Mantle Cell Lymphoma   Drs Peter Martin and Kami Maddocks discuss bendamustine, its effectiveness in older patients, and the challenge of combining treatments or other medications with that backbone.
  Medscape, February 28, 2023
• S2 Episode 1: Immunotherapy and Small Cell Lung Cancer   Drs Jacob Sands and Jared Weiss discuss subtypes; ongoing clinical trials; durable, ongoing responses to therapy; and the potential for using the word 'cure' in the treatment of small cell lung cancer.
  Medscape, February 16, 2023
• Episode 2: Mantle Cell Lymphoma International Prognostic Index and MRD   Drs Peter Martin and Eva Hoster discuss minimal residual disease, the Mantle Cell Lymphoma International Prognostic Index, and newer variable additions and their role in understanding recent findings.
  Medscape, January 31, 2023
• Episode 1: Autologous Stem Cell Transplant for Mantle Cell Lymphoma   Drs Peter Martin and Brad Kahl discuss autologous stem cell transplantation for mantle cell lymphoma, the TRIANGLE trial results, and the transition toward use of Bruton tyrosine kinase inhibitors.
  Medscape, January 31, 2023
• Analyzing Disparities in the Treatment of Mantle Cell Lymphoma   Yazeed Sawalha, MD, discusses a study that analyzed how health disparities affect the likelihood of undergoing consolidated autologous stem cell transplant for mantle cell lymphoma.
  Medscape, January 26, 2023
• Recognizing the Many Faces of Mantle Cell Lymphoma   Ann S. LaCasce, MD, MMSc, looks back and describes what she wishes she understood about mantle cell lymphoma at the start of her career.
  Medscape, January 23, 2023
• Tracing a Memorable Patient's Journey With Mantle Cell Lymphoma   Ann S. LaCasce, MD, recalls the progress of a patient with mantle cell lymphoma for 14 years.
  Medscape, January 23, 2023
• Recognizing the Heterogenous Nature of Mantle Cell Lymphoma   Kami Maddocks, MD, explores the diverse disease course of mantle cell lymphoma and the importance of finding the right therapy for the right patient.
  Medscape, January 19, 2023
• A Patient Experience That Illustrates the Changing Treatment Landscape in Mantle Cell Lymphoma   Suchitra Sundaram, MD, recounts the lack of therapeutic options in mantle cell lymphoma at the beginning of her career and the quickly evolving landscape thereafter.
  Medscape, January 19, 2023
• An Impactful Patient Experience That Has Altered My Approach to Mantle Cell Lymphoma   Suchitra Sundaram, MD, recalls one of her earliest interactions with a patient with mantle cell lymphoma.
  Medscape, January 18, 2023
• More Guidance Needed for Cancer Screening in Rheumatology Karmela Kim Chan, MD, discusses new myositis cancer screening guidelines as a good starting point for future needed efforts to guide cancer screening in patients with rheumatic diseases.
  Hospital for Special Surgery, January 12, 2023
• Mantle Cell Lymphoma: Understanding the Ferocity of Relapse   Tycel J. Phillips, MD, reflects on the variability in disease course for mantle cell lymphoma.
  Medscape, January 12, 2023
• Breakthroughs in Mantle Cell Lymphoma From ASH 2022   The beginning of the end for upfront stem cell transplants and chemotherapy, plus novel relapsed/refractory therapies, are among Dr Peter Martin's highlights in mantle cell lymphoma from ASH 2022.
  Medscape, January 04, 2023